The Next Wave of Cancer Therapies: Allogeneic Cell Therapies and Other Pioneers

8:30 AM - 9:40 AM, Tuesday, October 22, 2019 ・ 2nd Floor
As the industry continues to do revolutionary research on cancer, a host of new treatment options for therapies are showing promising data to disrupt the spread of tumors and inching us closer to a world where cancers can be cured. This panel reviews emerging treatment options in cancer, including the next wave of CAR-T, NK cell, and other pioneering approaches, highlighting promises enabled by each and the challenges to be resolved on the path to approvals and helping patients worldwide.

Moderator: Amanda Murphy, Managing Director, Research (Biotechnology)
Speakers
photo
EVP of Research & Development and Chief Medical Officer
Allogene
photo
CEO
ImmunoMet Therapeutics
photo
Chief Executive Officer
Century Therapeutics
photo
Chief Scientific Officer
Senti Bio
photo
Managing Director, Research (Biotechnology)
BTIG
Kanya
Senior Vice President & Chief Medical Officer
Nkarta Therapeutics